The Difference Between GLP-1 and GLP-2

The difference between GLP-1 and GLP-2 is mostly about function: GLP-1 regulates blood sugar and appetite, while GLP-2 protects and rebuilds the intestinal lining. Both are gut hormones in the incretin family, and both are cut from the same parent protein, but they bind different receptors and treat very different conditions. GLP-1 is the target of popular diabetes and weight-loss drugs, while GLP-2 is used in a rare intestinal disorder.

What GLP-1 Does in the Body

GLP-1 (glucagon-like peptide-1) is released by L-cells in the lower small intestine and colon after a meal. From there it acts on the pancreas, stomach, and brain.

• Signals the pancreas to release insulin, but only when blood glucose is already elevated.
• Suppresses glucagon, the hormone that pushes blood sugar higher.
• Slows gastric emptying so glucose enters the bloodstream more gradually.
• Increases satiety and reduces overall food intake.

Those combined effects explain why GLP-1 receptor agonists such as semaglutide and liraglutide are FDA-approved for type 2 diabetes and weight management. Natural GLP-1 survives only one to two minutes in circulation because the enzyme DPP-4 degrades it.

What GLP-2 Does in the Body

GLP-2 (glucagon-like peptide-2) is also secreted by intestinal L-cells, but it works locally on the gut rather than on metabolism.

• Promotes growth of cells in the intestinal crypts.
• Reduces programmed cell death along the gut lining.
• Boosts absorption of nutrients and fluids.
• Supports the intestinal barrier and lowers permeability.

GLP-2 does not meaningfully lower blood sugar and does not cause weight loss. Teduglutide, a longer-acting GLP-2 analog sold as Gattex, is FDA-approved for short bowel syndrome, a condition in which the gut cannot absorb enough nutrition.

GLP-1 vs GLP-2: Side-by-Side Comparison

Feature	GLP-1	GLP-2
Primary role	Glucose control and appetite regulation	Intestinal growth and repair
Main target tissues	Pancreas, brain, stomach	Small and large intestine
Native half-life	About 1 to 2 minutes	About 7 minutes
DPP-4 degradation	Rapidly broken down	Largely resistant
Approved drug examples	Semaglutide, liraglutide, dulaglutide	Teduglutide
Typical clinical use	Type 2 diabetes, obesity	Short bowel syndrome
Effect on body weight	Weight loss is common	Weight neutral or weight gain

The two hormones are not interchangeable and they are not competitors. A GLP-1 drug cannot repair a damaged intestine, and a GLP-2 drug will not produce weight loss.

Why the Two Are So Often Confused

GLP-1 and GLP-2 share a name, a source, and a parent molecule. Both are produced when the proglucagon gene is processed in intestinal L-cells, so they are literally siblings from the same genetic recipe.

Media coverage makes the confusion worse. GLP-1 has become shorthand for a whole class of blockbuster injections, so many people assume any GLP peptide does the same thing. GLP-2 almost never appears in that conversation because it treats a rare condition rather than obesity.

One easy rule: if the topic is blood sugar, appetite, or weight, you are almost certainly reading about GLP-1. If the topic is intestinal absorption, gut barrier function, or short bowel syndrome, it is GLP-2.

Receptors, Half-Life, and Drug Design

The GLP-1 receptor sits on pancreatic beta cells, in the hypothalamus, and in the gut. The GLP-2 receptor is concentrated in the intestine and in parts of the brain. Different receptors mean different downstream signals and different side effect profiles.

Because natural GLP-1 disappears within minutes, manufacturers modify the peptide backbone or attach fatty acid chains so the molecule resists DPP-4. That engineering is what turned a short-lived hormone into a once-weekly injection. GLP-2 analogs instead rely on a single amino acid substitution that blocks DPP-4 cleavage.

Curious researchers sometimes ask about sermorelin and glp-1 together, since both peptides circulate in the same online communities. Sermorelin stimulates growth hormone release, which is a completely separate hormonal pathway, and there is no established clinical protocol for combining the two.

Research Peptides and Naming Confusion

Beyond prescriptions, a gray market sells research-grade GLP peptides for laboratory use only. These products are not FDA-approved, are not verified for purity or sterility, and should never be treated as equivalent to pharmaceutical GLP-1 drugs.

Naming gets even messier in that space. People search how to mix glp-3 with bac water or look for ion peptides glp 3r 10mg, even though GLP-3 is not a recognized human hormone. Similar mix-ups show up in questions like What is the difference between KPV and BPC-157?, where two unrelated repair peptides get compared because their names sound alike.

It also helps to understand the difference between peptides and copper peptides. Copper peptides are topical skincare ingredients that deliver copper to the skin, and they have no effect on blood sugar, appetite, or the gut.

Safety, Side Effects, and Clinical Bottom Line

GLP-1 receptor agonists are well studied and generally well tolerated, but they commonly cause nausea, vomiting, diarrhea, and constipation. Less common risks include pancreatitis and gallbladder disease, and loss of muscle mass is a growing concern during rapid weight loss.

GLP-2 therapy can cause similar gastrointestinal symptoms, plus fluid retention and possible growth of existing intestinal polyps, which is why patients on teduglutide need regular monitoring.

Neither hormone is a supplement, and neither should be self-prescribed from an unregulated vendor. Anyone considering a GLP-1 or GLP-2 medication should review the risks, interactions, and alternatives with a licensed healthcare professional.

In short: GLP-1 is a metabolic hormone built for glucose control and appetite, and GLP-2 is a gut-tropic hormone built for intestinal maintenance. Same family, same gene, entirely different jobs.

COMMON QUESTIONS

Frequently Asked Questions

What is the main difference between GLP-1 and GLP-2?

GLP-1 controls blood sugar and appetite by boosting insulin release, slowing gastric emptying, and increasing fullness. GLP-2 works on the intestine instead, promoting cell growth in the gut lining and improving nutrient absorption. They bind different receptors and are used for completely different medical conditions.

Is GLP-2 used for weight loss like GLP-1?

No. GLP-2 does not drive weight loss and is generally weight neutral, and some patients on GLP-2 therapy actually gain weight as their intestines absorb more nutrients. The only FDA-approved GLP-2 analog, teduglutide, is indicated for short bowel syndrome rather than obesity.

Do GLP-1 and GLP-2 come from the same gene?

Yes. Both hormones are derived from the proglucagon gene, which is processed differently depending on the tissue. In intestinal L-cells, that processing yields GLP-1, GLP-2, and related peptides, which is why the two share a name even though their jobs are unrelated.